Last reviewed · How we verify
Chronic eosinophilic leukemia
Approved treatments
- Gleevec · M.D. Anderson Cancer Center
- Gleevec · Novartis
Gleevec works by blocking the activity of specific enzymes involved in cancer cell growth and proliferation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic eosinophilic leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Chronic eosinophilic leukemia treatment landscape brief
- Chronic eosinophilic leukemia treatment updates RSS
Frequently asked questions about Chronic eosinophilic leukemia
What drugs treat Chronic eosinophilic leukemia?
Tracked treatments include Gleevec.
What is the treatment for Chronic eosinophilic leukemia?
Standard treatment for Chronic eosinophilic leukemia includes Gleevec. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic eosinophilic leukemia patent cliff · Chronic eosinophilic leukemia CI report
- Treatment: Gleevec · M.D. Anderson Cancer Center
- Treatment: Gleevec · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing